{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:45:37Z","timestamp":1773297937445,"version":"3.50.1"},"reference-count":17,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1949,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1111\/j.1365-2354.2009.01068.x","type":"journal-article","created":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T16:37:19Z","timestamp":1248194239000},"page":"403-407","source":"Crossref","is-referenced-by-count":6,"title":["The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy - a retrospective audit"],"prefix":"10.1155","volume":"19","author":[{"given":"W.L.","family":"NG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"DELLA-FIORENTINA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","reference":[{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB1","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment","volume":"24","author":"Bloechl-Daum","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB3","unstructured":"Cancer Therapy Evaluation Program (2003) Common Terminology Criteria for Adverse Events, Version 3.0. DCTD, NCI, NIH, DHHS. Available at: http:\/\/ctep.cancer.gov\/"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB2","unstructured":"CI-SCaT (Standard Cancer Treatment Program) (2006) Antiemetics, Moderate Emetogenicity, Pre-chemotherapy Medications. Cancer Institute NSW. Available at: https:\/\/www.treatment.cancerinstitute.org.au"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB4","unstructured":"Commonwealth of Australia (2007) Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medial Practitioners. Australian Government Department of Health and Ageing 2007. Available at: http:\/\/www.pbs.gov.au\/html\/home"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1053\/bbmt.2001.v7.pm11760147","article-title":"Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation","volume":"7","author":"Fox-Geiman","year":"2001","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/sonc.2002.31535","article-title":"New agents, new treatment, and antiemetic therapy","volume":"29","author":"Gralla","year":"2002","journal-title":"Seminars in Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB7","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/annonc\/mdg417","article-title":"Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron","volume":"14","author":"Gralla","year":"2003","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB8","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/JCO.2006.06.9591","article-title":"American society of Clinical Oncology guideline for antiemetics in oncology: update 2006","volume":"24","author":"Kris","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1345\/aph.10014","article-title":"Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study","volume":"35","author":"McCune","year":"2001","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB13","unstructured":"MIMS Online (2007) Abbreviated Prescribing Information: Ondansetron hydrochoride. Available at: http:\/\/www.mims.com.au"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s005200050078","article-title":"Effect of postchemotherapy nausea and vomiting on health-related quality of life: the quality of life and symptom control committees of the national cancer institute of Canada clinical trials group","volume":"5","author":"Osoba","year":"1997","journal-title":"Supportive Care in Cancer"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1998.16.2.754","article-title":"Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study","volume":"16","author":"Perez","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB12","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/cncr.11433","article-title":"Addition of the neurokinin-1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting","volume":"97","author":"Poli-Bigelli","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/annonc\/mdj078","article-title":"Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference","volume":"17","author":"Roila","year":"2006","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1634\/theoncologist.8-2-187","article-title":"Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control","volume":"8","author":"Schnell","year":"2003","journal-title":"Oncologist"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000227458","article-title":"Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Cancer Patients","volume":"52","author":"Stewart","year":"1995","journal-title":"Oncology"},{"key":"10.1111\/j.1365-2354.2009.01068.x-BIB17","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","article-title":"Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy","volume":"23","author":"Warr","year":"2005","journal-title":"Journal of Clinical Oncology"}],"container-title":["European Journal of Cancer Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2354.2009.01068.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2354.2009.01068.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:10:04Z","timestamp":1671541804000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2354.2009.01068.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2354.2009.01068.x","relation":{},"ISSN":["0961-5423","1365-2354"],"issn-type":[{"value":"0961-5423","type":"print"},{"value":"1365-2354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}